THINC-it Vortioxetine - Sensitivity to Change
NCT03053362
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
158
Enrollment
OTHER
Sponsor class
Conditions
Major Depressive Disorder
Cognitive Change
Interventions
DRUG:
Vortioxetine
OTHER:
THINC-it Tool
Sponsor
Brain and Cognition Discovery Foundation